CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
We have now added a new section called the "Assay History List" to the "At A Gla...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
We are very excited to launch our new website! Please take a few moments to click around and explore...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...